Isaksson, B., Hultberg, B., Hansson, L., et al. (1999) Effect of Mesocaval Interposition Shunting and Repeated Sclerotherapy on Blood Levels of Gastrointestinal Regulatory Peptides, Amino Acids, and Lysosomal Enzymes—A Prospective Randomised Trial. Liver, 19, 3-11.
https://doi.org/10.1111/j.1478-3231.1999.tb00002.x

has been cited by the following article:

• TITLE: Progress and Prospects of Surgical Treatment of Portal Hypertension

  AUTHORS: Linjun Ruan, Buqiang Wu

  KEYWORDS: Portal Hypertension, Surgical Treatment, Devascularization, Shunt, Transjugular Intrahepatic Portosystemic Shunt, Liver Transplantation

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.11, November 17, 2023

  ABSTRACT: Portal hypertension is a group of syndrome characterized by splenic hyperfunction, esophageal and gastric varices and ascites caused by abnormal portal vein hemodynamics. Among them, upper gastrointestinal bleeding caused by esophageal and gastric varices is the most dangerous complication, which often threatens the lives of patients. After half a century of development, the treatment of portal hypertension is divided into two categories: medical drug therapy, endoscopic therapy and surgical treatment. With the understanding of portal hypertension and the continuous development of medical technology, the surgical operation of portal hypertension has also been greatly improved, reducing postoperative complications and improving the quality of life of patients after operation. However, at present, there is no surgical method that can completely cure portal hypertension. This article reviews the progress of surgical treatment of portal hypertension in recent years, in order to provide reference for the surgical treatment of portal hypertension.